- Home
- ARCT vs EU Comparison
ARCT vs EU Comparison
Compare ARCT & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- EU
- Stock Information
- Founded
- ARCT 2013
- EU 2009
- Country
- ARCT United States
- EU United States
- Employees
- ARCT N/A
- EU N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- EU Other Metals and Minerals
- Sector
- ARCT Health Care
- EU Basic Materials
- Exchange
- ARCT Nasdaq
- EU Nasdaq
- Market Cap
- ARCT 298.3M
- EU N/A
- IPO Year
- ARCT N/A
- EU N/A
- Fundamental
- Price
- ARCT $13.78
- EU $2.93
- Analyst Decision
- ARCT Strong Buy
- EU Strong Buy
- Analyst Count
- ARCT 8
- EU 1
- Target Price
- ARCT $52.83
- EU $2.75
- AVG Volume (30 Days)
- ARCT 484.1K
- EU 3.5M
- Earning Date
- ARCT 08-04-2025
- EU 08-13-2025
- Dividend Yield
- ARCT N/A
- EU N/A
- EPS Growth
- ARCT N/A
- EU N/A
- EPS
- ARCT N/A
- EU N/A
- Revenue
- ARCT $143,680,000.00
- EU $46,179,000.00
- Revenue This Year
- ARCT N/A
- EU $27.46
- Revenue Next Year
- ARCT $34.79
- EU $140.12
- P/E Ratio
- ARCT N/A
- EU N/A
- Revenue Growth
- ARCT 15.38
- EU N/A
- 52 Week Low
- ARCT $8.04
- EU $1.01
- 52 Week High
- ARCT $25.88
- EU $4.44
- Technical
- Relative Strength Index (RSI)
- ARCT 57.25
- EU 71.64
- Support Level
- ARCT $12.65
- EU $2.25
- Resistance Level
- ARCT $14.09
- EU $2.93
- Average True Range (ATR)
- ARCT 0.93
- EU 0.20
- MACD
- ARCT 0.05
- EU 0.04
- Stochastic Oscillator
- ARCT 60.04
- EU 96.81
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.